A Diploma in Pharmacy. Must have registered with Tamil Nadu Pharmacy Council and must keep the Registration alive by renewing it regularly every year.

Ph.D. degree in any area of Life Sciences / MSc degree with 4 years research experience with at least one international publication 

M.Sc. in Botany / Life Sciences / Biotechnology / Biochemistry / Agricultural Sciences / Plant Sciences equivalent degree with CSIR / UGC NET-JRF or DBT JRF, GATE or CSIR-LS rank holder, DST-INSPIRE applicant

M.Sc. in Biological subject / Chemistry / Biochemistry. 2 years experience in Cancer Research.

First class Master degree in Microbiology/ Biotechnology/ Microbial Biotechnology. Microbial Assisted Bio / Phytoremediation of Municipal Waste Dump Sites in the Central Himalaya

M.Sc Microbiology, Fermentation Technology, Biotechnology Or B.E, B.Tech. Chemical Engineering, Biochemical Engineering, Fermentation Technology, Biotechnology.

Help to recruit participants required for the project and explain the procedure to the participants and family members

Biological E. Limited (BE) invites both experienced professionals and fresh diploma holders, as well as graduates and self-driven individuals

Hetero is one of worlds leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector.

Handle manufacturing skids, Fedegari autoclaves isolator, lyophilizers, vial washing and tunnel, vial/ ophthalmic/ PFS filling and aseptic filtration

Preparation/review of medical and scientific write up. Coordination for serious adverse event reporting and safety update to Regulatory agency

Knowledge of handling HPLC, UV, Karl Fischer, Autotitrator, GC and dissolution in sterile and non-sterile.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world.

NATCO Pharmas Active Pharmaceutical Ingredient (API) facility located in Mekaguda, near Hyderabad, has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration

Zydus Lifesciences Limited has received tentative approval from the U.S. Food and Drug Administration (USFDA) to market Ibrutinib tablets in three strengths — 140 mg, 280 mg, and 420 mg. The approved products are generic versions of Imbruvica®, a widely used cancer medication in the United States.

Diploma in Pharmacy or B-Pharma Degree in Pharmacy or M-Pharma Degree in Pharmacy as approved by any University established by law or any other institution recognized by the State Government in this behalf

Ph.D. in Pharmaceutical Technology, Pharmaceutics, Industrial Pharmacy with M.Pharm, M.S.(Pharm.) in Pharmaceutical Technology (Formulations), Pharmaceutics, Industry Pharmacy. At least one research paper in SCI indexed journal.

D.Pharm / B.Pharm. Registered Pharmacists Certificate Valid as on date of interview.

M.Pharm in any of the following branch of Specialization - Pharmaceutics, Pharmacognosy, Pharmacology